Method of treating hyperlipemia
US4794115A · kind A · utility
16Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 1986 |
| Grant date | Dec 27, 1988 |
| Priority date | — |
| Expiry date | Oct 31, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating or preventing hyperlipemia by administering ethanolamine derivatives. As preferable ethanolamine derivatives are mentioned N-(9,12,15,-octadecatrienoyl)-2-aminoethyl nicotinate, N-(5,8,11,14,17-eicosapentaenoyl)-2-aminoethyl nicotinate and the like. Hyperlipemia is effectively prevented or treated by administering 300-2000 mg per day of said ethanolamine derivative for adults.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.